rs2376805
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000815.5(GABRD):c.69-19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.82 in 1,568,616 control chromosomes in the GnomAD database, including 528,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 50323 hom., cov: 36)
Exomes 𝑓: 0.82 ( 477942 hom. )
Consequence
GABRD
NM_000815.5 intron
NM_000815.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.221
Publications
17 publications found
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
- epilepsyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- epilepsy, idiopathic generalized, susceptibility to, 10Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-2024923-G-A is Benign according to our data. Variant chr1-2024923-G-A is described in ClinVar as Benign. ClinVar VariationId is 256824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABRD | NM_000815.5 | c.69-19G>A | intron_variant | Intron 1 of 8 | ENST00000378585.7 | NP_000806.2 | ||
| GABRD | XM_017000936.2 | c.755G>A | p.Arg252Gln | missense_variant | Exon 1 of 8 | XP_016856425.1 | ||
| GABRD | XM_011541194.4 | c.108-19G>A | intron_variant | Intron 1 of 8 | XP_011539496.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GABRD | ENST00000378585.7 | c.69-19G>A | intron_variant | Intron 1 of 8 | 1 | NM_000815.5 | ENSP00000367848.4 |
Frequencies
GnomAD3 genomes AF: 0.813 AC: 123660AN: 152152Hom.: 50293 Cov.: 36 show subpopulations
GnomAD3 genomes
AF:
AC:
123660
AN:
152152
Hom.:
Cov.:
36
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.803 AC: 200186AN: 249240 AF XY: 0.807 show subpopulations
GnomAD2 exomes
AF:
AC:
200186
AN:
249240
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.821 AC: 1162309AN: 1416348Hom.: 477942 Cov.: 23 AF XY: 0.820 AC XY: 579931AN XY: 707314 show subpopulations
GnomAD4 exome
AF:
AC:
1162309
AN:
1416348
Hom.:
Cov.:
23
AF XY:
AC XY:
579931
AN XY:
707314
show subpopulations
African (AFR)
AF:
AC:
26058
AN:
32554
American (AMR)
AF:
AC:
33141
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
AC:
22841
AN:
25764
East Asian (EAS)
AF:
AC:
28690
AN:
39438
South Asian (SAS)
AF:
AC:
65594
AN:
85166
European-Finnish (FIN)
AF:
AC:
44090
AN:
52304
Middle Eastern (MID)
AF:
AC:
4792
AN:
5684
European-Non Finnish (NFE)
AF:
AC:
888664
AN:
1072020
Other (OTH)
AF:
AC:
48439
AN:
58862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10380
20760
31140
41520
51900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19956
39912
59868
79824
99780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.813 AC: 123740AN: 152268Hom.: 50323 Cov.: 36 AF XY: 0.811 AC XY: 60364AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
123740
AN:
152268
Hom.:
Cov.:
36
AF XY:
AC XY:
60364
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
33027
AN:
41542
American (AMR)
AF:
AC:
11740
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
3139
AN:
3472
East Asian (EAS)
AF:
AC:
3730
AN:
5182
South Asian (SAS)
AF:
AC:
3771
AN:
4834
European-Finnish (FIN)
AF:
AC:
9002
AN:
10622
Middle Eastern (MID)
AF:
AC:
258
AN:
292
European-Non Finnish (NFE)
AF:
AC:
56472
AN:
68002
Other (OTH)
AF:
AC:
1751
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1286
2573
3859
5146
6432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2631
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Epilepsy, idiopathic generalized, susceptibility to, 10 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Idiopathic generalized epilepsy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.